Recipients of BC Cancer Foundation 2025 Rising Stars Graduate Awards competition announced
Congratulations to the recipients of the BC Cancer Foundation (BCCF) Rising Stars Graduate Awards competition!
This year’s awardees are:
News
Dr. Florian Kuchenbauer receives Pediatric Blood Cancer Research Innovation Grant
Dr. Florian Kuchenbauer, a distinguished researcher at BC Cancer, is the recipient of a Pediatric Blood Cancer Research Innovation Grant from the Leukemia & Lymphoma Society of Canada for his project titled, “Targeting O-GlcNAc Transferase in Pediatric EVI1-High Acute Myeloid Leukaemia.”
This grant is designed to challenge the current pediatric blood cancer landscape by providing funding for projects that will address unmet needs for pediatric blood cancers.
Congratulations to Dr. Kuchenbauer!
Yingying Liu receives the International Society for Experimental Hematology Travel Grant Award
Congratulations to Yingying Liu (Jiang Lab), a PhD student in the Collings Stevens Chronic Leukemia Research Laboratory, Department of Basic and Translational Research, for being awarded a prestigious ISEH Travel Grant Award.
Dr. Ly Vu receives Journey Award celebrating Canada’s outstanding immigrant women in STEMM
Congratulations to Dr. Ly Vu for receiving a Journey Award from the Canada Centre for Immigrant Women in STEM. The Journey Awards recognize and honour the journeys of immigrant women in STEMM who exemplify leadership, innovation and community service.
Dr. Vu is a scientist at BC Cancer, professor at UBC, and a Canada Research Chair in RNA biology in hematological malignancies.
Dr. Pamela Hoodless receives NSERC Discovery Grant
Congratulations to Dr. Pamela Hoodless for receiving a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (NSERC).
Dr. Hoodless, a distinguished researcher and Interim Head, Basic and Translational Research at BC Cancer, will use the grant to support her work in defining cell lineages and plasticity in the developing liver.
New Inpatient Clinical Trials Unit Launches in Vancouver to Advance Blood Cancer Treatment Across BC
British Columbia’s first dedicated inpatient clinical trials unit for early-phase therapies in blood cancers has been launched by Vancouver Coastal Health in collaboration with BC Cancer physicians and scientists. Located at Vancouver General Hospital (VGH), the new Hematology Research Unit will deliver revolutionary therapies — including first-in-human treatments such as advanced immunotherapies like CAR T-cell therapy — to patients with relapsed or treatment-resistant hematological diseases.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.